-
Pretreatment PET dissemination features as biomarkers for survival outcomes in melanoma patients treated with immune-checkpoint inhibitors
Saadani, H., Aalbersberg, E. A., Kayembe, M. T., Haanen, J. B. A. G., Hoekstra, O. S., Boellaard, R. & Stokkel, M. P. M., 1 Dec 2025, In: Scientific reports. 15, 1, 21570.Research output: Contribution to journal › Article* › Academic › peer-review
-
Comparing [18F]FDG PET/CT response criteria in melanoma and lung cancer patients treated with immunotherapy: a systematic review
Saadani, H., Aalbersberg, E. A., Schats, W., Hoekstra, O. S., Stokkel, M. P. M. & de Vet, H. C. W., Dec 2022, In: Clinical and translational imaging. 10, 6, p. 643-661 19 p.Research output: Contribution to journal › Review article* › Academic › peer-review
-
Metabolic biomarker–based BRAFV600 mutation association and prediction in melanoma
Saadani, H., Van der Hiel, B., Aalbersberg, E. A., Zavrakidis, I., Haanen, J. B. A. G., Hoekstra, O. S., Boellaard, R. & Stokkel, M. P. M., 1 Jan 2019, In: Journal of nuclear medicine. 60, 11, p. 1545-1552 8 p.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
